Details of the Drug

General Information of Drug (ID: DMVB5E1)

• Drug Name: NP001

Indication

Disease Entry	ICD 11	Status	REF
Amyotrophic lateral sclerosis	8B60.0	Phase 2	[1]
Alzheimer disease	8A20	Phase 1	[2]

• Drug Type: Small molecular drug
• Cross-matching ID: TTD ID: D1LU7W
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01281631) A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS). U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)